amantadine; adamantamine (Symmetrel, Gocovri)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Symmetrel.

Indications

Contraindications

pregnancy category = c

safety in lactation = ?

Dosage

Tabs: 100 mg.

Syrup: 50 mg/5 mL (480 mL).

Dosage adjustment in renal failure

Table

creatinine clearance dosage
> 50-90 mL/min every 24-48 hour dosing
10-50 mL/min every 48-72 hours dosing
< 10 mL/min* every 7 day dosing

* No additional dosing for hemodialysis

Pharmacokinetics

elimination via kidney

1/2life = 9-37 hours

protein binding = 67 %

elimination by hemodialysis = -

elimination by peritoneal dialysis = -

Adverse effects

Drug interactions

Mechanism of action

More general terms

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996.
  2. 2.0 2.1 AHFS 96 Drug Information, GK McEnvoy et al (ed), American Society of Health-System Pharmacists, Bethesda, MD 1996, pg 432, 2703
  3. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  4. 4.0 4.1 4.2 Prescriber's Letter 8(10):56 2001
  5. Sanford Guide to antimicrobial therapy 2001
  6. Prescriber's Letter 10(11) 2003; detail document 191102
  7. 7.0 7.1 7.2 Prescriber's Letter 11(1):1 2004
  8. 8.0 8.1 8.2 8.3 8.4 Bronstein J, In: Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 29-Oct 2, 2004
  9. 9.0 9.1 9.2 Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005 Oct 1;366(9492):1175-81. Epub 2005 Sep 22. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16198766
    Centers for Disease Control and Prevention (CDC). High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents: United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep. 2006 Jan 20;55(2):44-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16424859
    Prescriber's Letter 13(2): 2006 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=220202&pb=PRL (subscription needed) http://www.prescribersletter.com
    Bright RA et al, Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16456807
    Centers for Disease Control and Prevention (CDC). CDC recommends against use of amantadine and rimantadine for the treatment of prophylaxis of influenza during the 2005- 2006 flu season. CDC Health Alert Network 2006, Jan 14 http://www.cdc.gov/flu/han011406.htm
  10. 10.0 10.1 10.2 Medical Knowledge Self Assessment Program (MKSAP) 15, 16. American College of Physicians, Philadelphia 2009, 2012
  11. Department of Veterans Affairs, VA National Formulary
  12. 12.0 12.1 Brooks M FDA Clears First Drug for Parkinson's Dyskinesia Medscape - Aug 25, 2017. http://www.medscape.com/viewarticle/884697

Database